Novartis, Bayer and patent drafting: what’s on this week

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Novartis, Bayer and patent drafting: what’s on this week

Managing IP lists the IP events and lawsuits taking place this week



Tuesday August 21, 2012


The IP Office of the Philippines will be holding a course, Patent Drafting II, for examination passers only, location TBC

Hearing before India’s Intellectual Property Appellate Board in Natco v Bayer, concerning the compulsory license granted to Natco to manufacture generic versions of Bayer’s sorafenib.

Wednesday August 22


India’s Supreme Court is due to hear final arguments between Switzerland’s Novartis against India's patent office over its refusal to grant a patent over cancer drug Glivec.

The USPTO is seeking volunteers to test the new electronic filing system for administrative trials linked to post grant review, inter partes review and the transitional programme for covered business methods.

Friday August 24, 2012


The IP Office of the Philippines will be hosting a meeting with the Japan-Asia Young Scientist & Engineer Study (JAYSES) at its offices in Taguig City.

Last day of Apple v Samsung trial in California.



more from across site and SHARED ros bottom lb

More from across our site

New filing data suggests Germany's grip on UPC litigation remains strong, while Bardehle Pagenberg, Arnold Ruess, Hogan Lovells and Carpmaels notch up notable cases
In 27 years, KASS has expanded to seven countries in southeast Asia and is now eyeing further growth opportunities. Its CEO shares her perspective
Mine Güner discusses bridging law and business, taking the initiative, and why Taylor Swift helped put copyright on the map
Cindy Goh discusses why she launched Cheang & Ariff's IP department, the improving litigation environment in Malaysia and what to consider when using AI
Increased focus on adding patent litigation depth to the firm’s Dallas office was behind the boutique’s most recent hires
IPH's Canadian acquisitions are paying off on paper, but a couple of strong years may not be enough to show that the group's strategy has truly won over the market
Examiner statistics could help patent prosecution practitioners tailor strategies, turning an area of high variability into a potential competitive advantage
The England and Wales High Court’s ruling in Accord v Novartis may not rewrite the law on plausibility, but it does signal a pragmatic approach that could provide greater certainty for life sciences innovators
Firms with established sports relationships and specialised expertise are well positioned to capture the market’s expanded pool of IP work
Gunjan Paharia discusses developing RIA, an AI platform built to draw on decades of institutional knowledge, support junior lawyers, and reshape how legal teams work
Gift this article